Prenatal Diagnosis Thalassaemia
Prenatal Diagnosis Thalassaemia
Prenatal Diagnosis Thalassaemia
Prenatal diagnosis is done to know about the status of disease in fetus before it is born. It is usually done to
know about a genetic disorder or congenital malformation in the fetus. The basic objective is to provide an
informed choice to the parents. If the fetus is healthy then the parents are reassured. When the fetus has a
serious genetic abnormality or malformation then the parents have the choice to either terminate the
pregnancy or to accept the child with genetic abnormality.
Prenatal diagnosis can be done by either invasive or non-invasive methods. The commonest non-invasive
method is by ultra-sound examination. Several congenital malformations may be suspected as early as 12
weeks of gestation and confirmed by 18 weeks. A more recent addition to the list of non-invasive prenatal
diagnosis is by testing of fetal DNA abnormalities in the maternal blood. The invasive method of prenatal
diagnosis involves fetal sampling by Chorionic Villus Sampling (CVS) or amniocentesis. The fetal sample
may be tested for a large number of single gene disorders or chromosomal defects.
GRC offers comprehensive facility for invasive prenatal diagnosis of many common single genetic
disorders like thalassaemia, cystic fibrosis, Duchenne Muscular Dystrophy and trisomies 13, 18 & 21. GRC
provides comprehensive facility under one roof for fetal sampling and the genetic testing.
Thalassaemia major is a difficult and expensive disease to treat. The births of children with thalassaemia
major can be prevented by early prenatal diagnosis and selective termination of the affected pregnancies.
The first step in prenatal diagnosis involves identification of the Beta thalassaemia mutation in the father
and the mother. In the next step the fetal sample is taken and is tested for the parent’s mutations. It usually
takes about a week to get the result. The error rate in prenatal diagnosis is around 0.5%.
In 1994 Pakistan became the first Muslim country to start a clinical service for prenatal diagnosis of
thalassaemia. The fetal sample was taken by Dr. Yasmeen Rashid at Lady Wellington Hospital Lahore and
its DNA testing was done by Dr. Suhaib Ahmed at the Armed Forces Institute of Pathology (AFIP),
Rawalpindi. Since then over 8,000 prenatal diagnoses for thalassaemia have been done in Punjab and
Khyber Pakhtunkhawa. In the last couple of years over 90% of the workload of prenatal diagnosis of
thalassaemia has shifted to GRC. In 2014 GRC did over 1000 prenatal diagnoses for thalassaemia. It forms
almost 80% of the total number of prenatal diagnoses for thalassaemia done in Pakistan.
1200
1000
800
600
400
200
0
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014